Plus Products Launches New PLUS SLEEP Brand, Extends Portfolio of Best-Selling Cannabis Gummies

September 3, 2020 at 7:30 AM EDT

SAN MATEO, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”), a cannabis and hemp branded products company in the U.S., today announced the launch of its new PLUS SLEEP brand into the California adult-use market.


  • 4 key ingredients to promote a well-rounded night of sleep: THC, CBN, CBD, and just a touch of melatonin.
  • All-natural colors and flavors, with only 0.7g of sugar and 5 calories per gummy.
  • 2 formulations to offer multiple potential solutions to a wide range of consumers: Sleep Cloudberry, with 5mg of THC, 1mg of CBN, and 1mg of CBD, along with CBNRelief Lychee, with 1mg of THC, 2mg of CBN, and 3mg of CBD.

PLUS’s new SLEEP gummies are scientifically formulated with a precise blend of cannabinoids and melatonin intended to help consumers fall asleep quickly and enjoy a full, restful night’s sleep.

Recent research on the interaction between cannabis, the endocannabinoid system, and the body’s natural circadian rhythm¹ drove PLUS’s formulations of the two new SLEEP products. “Each cannabinoid was selected for how it promotes better sleep, but together they have the potential to be greater than the sum of their parts. This is often referred to as the entourage effect.2 We also included a physiologic dose of melatonin to support our bodies’ circadian rhythm, so these gummies actually work in concert with our natural systems,” stated Dr. Ari Mackler, Chief Scientific Officer. 

“We’re excited to help the 71% of cannabis sleep aid users who are not satisfied with their current remedies3,” stated Jake Heimark, CEO and Co-Founder. “Almost 50 million people in the US suffer from insomnia.4 It’s no surprise  we hear all the time that one of the top things people look for when they walk into a licensed retailer is something to help them sleep.”

 (1)[1] Hodges EL, Ashpole NM. Aging circadian rhythms and cannabinoids. Neurobiol Aging. 2019;79:110-118.  [2]. Hanlon EC. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide). Psychoneuroendocrinology. 2020;111:104471.  [3] Antony JM, McDonald AC, Noorbakhsh F, Guthrie N, Evans M. Changing the Tone of Clinical Study Design in the Cannabis Industry. Transl Neurosci. 2020;11:4-9.
 (2)Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364.
 (3)BrightField Consumer Survey (July 2020)
 (4)Ford ES, Cunningham TJ, Giles WH, Croft JB. Trends in insomnia and excessive daytime sleepiness among U.S. adults from 2002 to 2012. Sleep Med. 2015;16(3):372-378.
 (5)Title: PLUS was the best-selling gummies brand in California during the full year 2019 according to BDS analytics.

Upcoming Events To Learn More

  • Sleepy Time Series: Get tucked in every Tuesday night with PLUS! Throughout the month of September, PLUS is hosting a series of free Instagram Live sessions to help you unwind, ease your mind, and drift off to sleep! From breath work to yoga, wind down with PLUS from the comfort of your own bed! For more information visit
  • Bedtime Chat with the Experts: PLUS’s Chief Scientific Officer, Dr. Ari Mackler and Sleep Expert, Dr. Michael Breus (@thesleepdoctor) have teamed up for a live, virtual conversation on the science of sleep. On Monday, Sept 16th, they will decode how cannabis plays a role in sleep by providing a deep dive into the latest research on the interaction of cannabinoids on our bodies and sleep systems. To register for the free webinar, visit


California THC: PLUS cannabis-infused edibles are currently available in over 360 licensed retailers across the state of California. PLUS SLEEP edibles are expected to roll out to licensed retailers across the state in the coming weeks - visit to find participating locations.

Nevada THC: PLUS cannabis-infused gummies are currently available in licensed retailers throughout Las Vegas.

National Hemp CBD: PLUS 100% hemp CBD-infused gummies are available for purchase in 43 states across the country at

About PLUS

PLUS is a hemp and cannabis food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable – that begins with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, CA.

A photo accompanying this announcement is available at 
For further information contact:

Jake Heimark
CEO & Co-founder 


Blake Brennan
Investor Relations 

Tel +1 213.282.6987


Megan Sekkas
Public Relations 
Tel +310.279.6811

The CSE does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This press release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (each, a “forward-looking statement”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur and include, but are not limited to, statements relating to: (i) the extent to which, if at all, PLUS SLEEP gummies and the active ingredients within them will promote a better night’s sleep; (ii) the extent to which, if at all, PLUS SLEEP cannabis-infused gummies will be rolled-out across California in coming weeks.

These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this press release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the success of the Company’s investments, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of the Company’s products, customer experience and retention, the continued development of adult-use sales channels, managements estimation of consumer demand in in jurisdictions where the Company exports, expectations of future results and expenses, the availability of additional capital to complete capital projects and facilities improvements, the ability to expand and maintain distribution capabilities, the impact of competition, the ability of the Company to implement initiatives and the possibility for changes in laws, rules, and regulations in the industry. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.